7th International Immunoglobulin Conference: Neurology

E. Nobile-Orazio, R. A. Lewis

Research output: Contribution to journalArticlepeer-review


Data presented demonstrate the versatility of immunoglobulin (Ig) therapy for a variety of neurological disorders with different pathogenesis and presentations. In indications where the efficacy of Ig is well established, the neurology community is striving to improve the use of this valuable and limited resource by perfecting best practice guidelines, individualizing dosing schemes and investigating combination therapies to enhance treatment benefit. The data showing the efficacy of Ig therapy in conditions such as chronic pain and autoimmune encephalitis are promising. Future challenges for Ig use in neurological disorders were also outlined. Ongoing and upcoming randomized controlled trials will be pivotal to the use of Ig in the future, by identifying responder groups and elucidating the most effective administration practices. As our understanding and use of the therapy increases, it is essential that we collect data on the effects of long-term Ig treatment in neurological conditions, of which very little currently exists.

Original languageEnglish
Pages (from-to)45
Number of pages1
JournalClinical and Experimental Immunology
Issue numberS1
Publication statusPublished - Dec 1 2014

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy


Dive into the research topics of '7th International Immunoglobulin Conference: Neurology'. Together they form a unique fingerprint.

Cite this